Rubio Sends Letter to Pfizer CEO on Alleged Gain-of-Function ...

Senator Marco Rubio - 27 Jan 2023
An investigative report suggests that Pfizer may be conducting gain-of-function research, which it dubs “directed evolution” research to mutate the ...

FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder

CNBC - 26 Apr 2024
FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder ...

GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

Reuters - 25 Apr 2024
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology ...

End of Boulder R&D operations for Pfizer in Boulder

9News.com KUSA - 24 Apr 2024
End of Boulder R&D operations for Pfizer in Boulder ...

Pfizer confirms end of Boulder R&D operations - Denver Business Journal

The Business Journals - 23 Apr 2024
Pfizer confirms end of Boulder R&D operations - Denver Business Journal ...

Pfizer collab with Austrian research institute leads to new AI models for drug discovery

Fierce Biotech - 26 Apr 2024
Pfizer collab with Austrian research institute leads to new AI models for drug discovery ...

Takeda ditches industry trade group BIO following exits by WuXi AppTec, Pfizer and UCB

FiercePharma - 26 Apr 2024
Takeda ditches industry trade group BIO following exits by WuXi AppTec, Pfizer and UCB ...

Pfizer Declares Second-Quarter 2024 Dividend

Yahoo Finance - 24 Apr 2024
Pfizer Declares Second-Quarter 2024 Dividend ...

Pfizer and BioNTech commence legal action against Moderna in UK court

Pharmaceutical Technology - 24 Apr 2024
Pfizer and BioNTech commence legal action against Moderna in UK court ...

Better Buy: Pfizer vs. Viking Therapeutics

The Motley Fool - 23 Apr 2024
Better Buy: Pfizer vs. Viking Therapeutics ...

Analysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for

Yahoo Finance - 24 Apr 2024
Analysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for ...

Pfizer's First Gene Therapy Gets Approval for Clotting Disorder

Bloomberg - 26 Apr 2024
Pfizer's First Gene Therapy Gets Approval for Clotting Disorder ...

U.S. FDA Approves Pfizer's BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with ...

Business Wire - 26 Apr 2024
U.S. FDA Approves Pfizer's BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with ... ...

Pfizer Gets FDA OK For Beqvez Gene Therapy for Hemophilia B

MarketWatch - 26 Apr 2024
Pfizer Gets FDA OK For Beqvez Gene Therapy for Hemophilia B ...

GSK Sues Pfizer and BioNTech Over Alleged COVID-19 Patent Infringement

BioSpace - 26 Apr 2024
GSK Sues Pfizer and BioNTech Over Alleged COVID-19 Patent Infringement ...

GSK Hits Pfizer And BioNTech With COVID Vaccine Patent Suit

Law360 - 26 Apr 2024
GSK Hits Pfizer And BioNTech With COVID Vaccine Patent Suit ...

Use of the Pfizer Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the ...

CDC - 18 Apr 2024
Use of the Pfizer Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the ... ...

EC approves Pfizer's EMBLAVEO for multidrug-resistant infections

Pharmaceutical Technology - 23 Apr 2024
EC approves Pfizer's EMBLAVEO for multidrug-resistant infections ...

US FDA approves Pfizer's gene therapy for rare bleeding disorder

Reuters - 26 Apr 2024
US FDA approves Pfizer's gene therapy for rare bleeding disorder ...

Is Pfizer Stock, At An 11-Year Low, A Sell Amid The Search For Its Big Break?

Investor's Business Daily - 24 Apr 2024
Is Pfizer Stock, At An 11-Year Low, A Sell Amid The Search For Its Big Break? ...

Pfizer